Important Notice for RxSight, Inc Shareholders: Legal Rights Notification

Call for Shareholders of RxSight, Inc.

Investors in RxSight, Inc. (NASDAQ: RXST) have a critical opportunity to discuss their rights and possible actions they may take regarding their investments. As per the latest announcement from The Gross Law Firm, shareholders who acquired shares between November 7, 2024, and July 8, 2025, are strongly encouraged to reach out to the firm to understand their options better.

Understanding the Allegations

During the mentioned class period, it has been alleged that the company’s representatives made materially misleading statements. Some of the key points highlighted in the complaint include:
1. Adoption Challenges: The firm claimed that RxSight faced challenges in product adoption, which led to declines in sales and product usage.
2. Overstated Demand: Allegations have also surfaced that RxSight exaggerated the demand for its offerings, which could have affected market perceptions of the company’s growth potential.
3. Financial Guidance at Risk: The complaint suggests that due to these issues, the company was unlikely to meet the financial forecasts it had previously committed to for the fiscal year 2025.
4. Misleading Public Statements: The essence of the allegations rests on the idea that public statements made about the company's health and future prospects did not reflect the reality faced by the organization.

Given the severity of these allegations, shareholders are advised to take action and register for the class action lawsuit by visiting The Gross Law Firm’s dedicated page for RxSight. Notably, the deadline for registration is September 22, 2025, and missing this date could result in losing rights to any recovery that might arise from the litigation.

Next Steps for Interested Shareholders

Shareholders who decide to engage with The Gross Law Firm will benefit from enrollment in a portfolio monitoring service. This ensures they receive timely updates regarding the development of the case, including any crucial changes or decisions that might occur. It is essential to highlight that there are no costs or obligations for participating in this case, which allows shareholders to protect their investments without financial strain.

The Gross Law Firm’s mission focuses on safeguarding investor rights, especially those suffering losses due to corporate malpractice. By addressing unethical practices and pursuing rightful claims, the firm positions itself as a dedicated ally to individuals impacted by such financial misconduct.

How to Contact The Gross Law Firm

For shareholders wishing to discuss their individual situations, please reach out to The Gross Law Firm at:

- Address: 15 West 38th Street, 12th Floor, New York, NY 10018
- Email: [email protected]
- Phone: (646) 453-8903

In conclusion, if you are an investor in RxSight, Inc., this is a critical time to understand your options and take action. Time is of the essence as the deadline approaches, and being proactive could play a significant role in potential recovery efforts. Don’t hesitate to connect with The Gross Law Firm for further clarity and guidance on this matter.